Occurrence of glycosylation and deglycosylation of exogenously administered ganglioside GM1 in mouse liver.
Ganglioside GM1, 3H-labelled at the level of terminal galactose or of sphingosine, was intravenously injected into Swiss albino mice and some steps in its metabolic fate in the liver were investigated. After administration of [3H]sphingosine-labelled GM1 all major liver gangliosides [GM3, GM2, GM1, GD1a-(NeuAc,NeuGl)] became radioactive, the radioactivity residing in all cases on the sphingosine moiety. The specific radioactivity was highest in GM1, which carried about 53% of the radioactivity incorporated into gangliosides, followed by GM2, with 34.5% of incorporated radioactivity, GM3 and GD1a-(NeuAc,NeuGl), both with about 5% of incorporated radioactivity. After administration of [3H]galactose-labelled GM1 the only radioactive gangliosides present in the liver were GM1 and GD1a-(NeuAc,NeuGl), the former carrying about 95% of the total ganglioside-incorporated radioactivity, the latter about 3%. Both gangliosides were radioactive exclusively in the terminal galactose residue. According to these results exogenously administered GM1, after being taken up by the liver, is mainly degraded to GM2 and GM3, a part being, however, sialylated to GD1a-(NeuAc,NeuGl). All this suggests that exogenous GM1 may be involved in the metabolic routes of endogenous liver gangliosides.
D000818:Animals; D002241:Carbohydrates / Q000032:analysis; D002850:Chromatography, Gel; D005227:Fatty Acids / Q000032:analysis; D005677:G(M1) Ganglioside / Q000378:metabolism*; D005732:Gangliosides / Q000302:isolation & purification / Q000378:metabolism*; D050356:Lipid Metabolism; D008099:Liver / Q000378:metabolism*; D008297:Male; D051379:Mice; D009439:Neuraminidase; D013110:Sphingosine / Q000032:analysis
D002241:Carbohydrates; D005227:Fatty Acids; D005732:Gangliosides; D005677:G(M1) Ganglioside; D009439:Neuraminidase; D013110:Sphingosine